Baseline characteristics of study cohort by initial use of aromatase inhibitor (AI) or tamoxifen (TAM).
收藏NIAID Data Ecosystem2026-03-09 收录
下载链接：
https://figshare.com/articles/dataset/_Baseline_characteristics_of_study_cohort_by_initial_use_of_aromatase_inhibitor_AI_or_tamoxifen_TAM_/1222301
下载链接
链接失效反馈官方服务：
资源简介：
NOTE: Pharmacy data through December 31, 2013; Missing data for entire cohort: menopausal status (n = 9), BMI (n = 28), smoking (n = 13), alcohol (n = 552), vitamin supplements (n = 37).
1 Logistic regression adjusted for age at breast cancer diagnosis as a continuous variable.
2 Median (overall) = 3.10 g/day, median (postmenopausal women) = 2.90 g/day.
3 Osteoporosis defined by ICD-9 code (733.00–733.09) or any prior bisphosphonate prescription.
4 Major fracture includes fracture of spine, humerus, wrist, or hip.
Baseline characteristics of study cohort by initial use of aromatase inhibitor (AI) or tamoxifen (TAM).
创建时间：
2014-10-29
